[Metastasized colonic cancer. When are there no indications for primary resection?].

about

[Metastasized colonic cancer. When are there no indications for primary resection?].

Item

http://www.wikidata.org/entity/Q53147876

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

[Metastasized colonic cancer. When are there no indications for primary resection?].

@en

[Metastasized colonic cancer. When are there no indications for primary resection?].

@nl

type

Item

label

[Metastasized colonic cancer. When are there no indications for primary resection?].

@en

[Metastasized colonic cancer. When are there no indications for primary resection?].

@nl

prefLabel

[Metastasized colonic cancer. When are there no indications for primary resection?].

@en

[Metastasized colonic cancer. When are there no indications for primary resection?].

@nl

P1476

[Metastasized colonic cancer. When are there no indications for primary resection?].

@en

P2093

R Kube

http://www.w3.org/2001/XMLSchema#string

P2860

Initial presentation with stage IV colorectal cancer: how aggressive should we be?

Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS--a randomised controlled multicentre trial (ISRCTN30964555).

Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial.

Palliative treatment for incurable malignant colorectal obstructions: a meta-analysis.

Reassessing the need for primary tumor surgery in unresectable metastatic colorectal cancer: overview and perspective.

Prognostic value of resection of primary tumor in patients with stage IV colorectal cancer: retrospective analysis of two randomized studies and a review of the literature.

Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases.

Primary mFOLFOX6 plus bevacizumab without resection of the primary tumor for patients presenting with surgically unresectable metastatic colon cancer and an intact asymptomatic colon cancer: definitive analysis of NSABP trial C-10.

Palliative operations for colorectal cancer.

Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment.

P2888

s00104-014-2765-3

P304

148-153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00104-014-2765-3

http://www.w3.org/2001/XMLSchema#string

P407

Af-Jarmal

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P Mroczkowski

P577

2015-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263514097

http://www.w3.org/2001/XMLSchema#string

P698

24969343

http://www.w3.org/2001/XMLSchema#string